Tender Details

Country: Belarus
Summary: 8/24 Drug Ambroxol
BYT Ref No: 96567285
Deadline: 18 Feb 2024
Financier: Self Financed
Purchaser Ownership: Government
Tender Value: BYN 6358923
Notice Type: Tender
Document Ref. No.: AU20240207296182
Purchaser's Detail:
Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
Login to see details
Description:
8/24 drug Ambroxol
Industry: pharmacology drugs
Documents:

Tender Notice

AD_po_forme__692__Zareg_Ambroksol.doc

Prilogenie_2_spetzifikatziya.xlsx

Prilogenie__1_LPU_Mogilevskoi_oblasti_Ambroksol.xlsx

1_Dogovor_k_auktzionnym_dokumentam_sobst.sr_va_dlya_rezidentov_proizvoditelei.doc

2_Dogovor_k_auktzionnym_dokumentam_za_sobstv.sr_va_dlya_rezidentov_posrednikov.doc

3_Kontrakt_k_auktzionnym_dokumentam__za_sobstv._sr_va_dlya_nerezidentov_dlya_stran_EAES.doc

4_Kontrakt_k_auktzionnym_dokumentam_za_sobstv._sr_va_dlya_nerezidentov_krome_stran_EAES.doc

Prilogenie_k_dogovoru_postavki_s_rezidentom.xls

Prilogenie_k_kontraktu_s_nerezidentom.xlsx

au_purchase_296182.xls

If you are registered member, kindly login to view full details of this tender notice:

CLICK HERE TO LOGIN

8/24 Drug Ambroxol - Belarus Tender

The MOGILEV TRADE AND PRODUCTION REPUBLICAN UNITARY ENTERPRISE "PHARMACATION", a Government sector organization in Belarus, has announced a new tender for 8/24 Drug Ambroxol. This tender is published on BelarusTenders under BYT Ref No: 96567285 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2024-02-18.

The estimated tender value is BYN 6358923, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.